GILD
Gilead Sciences, Inc. · VIE:GILD
150.70 EUR−3.84 −2.48%
Gilead Sciences, Inc. (VIE:GILD) last traded at 150.70 EUR, down 2.48% on the day. Over the past year the stock is up 49.09%. Its 52-week range is 99.98 to 154.92. It is in the Health Technology sector (Biotechnology).
Key statistics
Open151.70
Day range150.52 – 152.32
52-week range99.98 – 154.92
Volume155
Average volume (10 days)51
Market cap (USD)211.64 B
EPS (TTM) (USD)−3.15
Dividend yield1.90%
Beta (1 year)−0.0759
Revenue (TTM) (USD)31.06 B
Employees17.00 K
Performance
+8.17%1 week
+14.60%1 month
+32.66%3 months
+33.15%6 months
+43.91%Year to date
+49.09%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
- Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
- Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
- Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.